JP2016505003A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016505003A5 JP2016505003A5 JP2015549902A JP2015549902A JP2016505003A5 JP 2016505003 A5 JP2016505003 A5 JP 2016505003A5 JP 2015549902 A JP2015549902 A JP 2015549902A JP 2015549902 A JP2015549902 A JP 2015549902A JP 2016505003 A5 JP2016505003 A5 JP 2016505003A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- biological sample
- mammalian
- binding
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012905669 | 2012-12-24 | ||
| AU2012905669A AU2012905669A0 (en) | 2012-12-24 | Vaccine booster | |
| AU2012905667A AU2012905667A0 (en) | 2012-12-24 | Vaccines for treatment of cancer | |
| AU2012905667 | 2012-12-24 | ||
| AU2013203806 | 2013-04-11 | ||
| AU2013203806A AU2013203806B2 (en) | 2012-12-24 | 2013-04-11 | Vaccines for the treatment or prevention of cancer |
| AU2013903592A AU2013903592A0 (en) | 2013-09-18 | Vaccines for the treatment or prevention of cancer | |
| AU2013903592 | 2013-09-18 | ||
| PCT/AU2013/001523 WO2014100857A1 (en) | 2012-12-24 | 2013-12-24 | Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018017162A Division JP2018111695A (ja) | 2012-12-24 | 2018-02-02 | がんの治療のためのワクチン及びワクチン有効性を増強するための組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016505003A JP2016505003A (ja) | 2016-02-18 |
| JP2016505003A5 true JP2016505003A5 (enExample) | 2017-02-09 |
| JP6286445B2 JP6286445B2 (ja) | 2018-02-28 |
Family
ID=53547734
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015549902A Expired - Fee Related JP6286445B2 (ja) | 2012-12-24 | 2013-12-24 | がんの治療のためのワクチン及びワクチン有効性を増強するための組成物 |
| JP2018017162A Pending JP2018111695A (ja) | 2012-12-24 | 2018-02-02 | がんの治療のためのワクチン及びワクチン有効性を増強するための組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018017162A Pending JP2018111695A (ja) | 2012-12-24 | 2018-02-02 | がんの治療のためのワクチン及びワクチン有効性を増強するための組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10357538B2 (enExample) |
| EP (2) | EP2934578B1 (enExample) |
| JP (2) | JP6286445B2 (enExample) |
| AU (1) | AU2013370932B2 (enExample) |
| CA (1) | CA2934958A1 (enExample) |
| NZ (1) | NZ629700A (enExample) |
| WO (1) | WO2014100857A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10357538B2 (en) * | 2012-12-24 | 2019-07-23 | Northern Sydney Local Health District | Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy |
| US11975068B2 (en) | 2016-02-04 | 2024-05-07 | Longeveron, Inc. | Mesenchymal stem cells as vaccine adjuvants and methods for using the same |
| US20190030152A1 (en) * | 2016-04-01 | 2019-01-31 | Apceth Gmbh & Co. Kg | Mesenchymal stem cells to enhance anti-tumor activity of immunotherapy |
| BR112020015291B1 (pt) * | 2018-03-19 | 2023-09-26 | Regeneron Pharmaceuticals, Inc | Tampão de amostra de eletroforese aquoso, método para identificar contaminantes ou impurezas em uma amostra de fármaco proteico, e, kit |
| US12259355B2 (en) | 2018-03-19 | 2025-03-25 | Regeneron Pharmaceuticals, Inc. | Microchip capillary electrophoresis assays and reagents |
| US12253490B2 (en) | 2018-03-19 | 2025-03-18 | Regeneron Pharmaceuticals, Inc. | Microchip capillary electrophoresis assays and reagents |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62221636A (ja) * | 1986-03-20 | 1987-09-29 | Chemo Sero Therapeut Res Inst | Ｂ型肝炎ウイルス抗原蛋白の可溶化方法 |
| US5030621A (en) | 1987-04-23 | 1991-07-09 | Bystryn Jean Claude | Shed melanoma antigen compositions |
| JPH0832638B2 (ja) | 1989-05-25 | 1996-03-29 | カイロン コーポレイション | サブミクロン油滴乳剤を含んで成るアジュバント製剤 |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| US6379671B1 (en) | 1996-08-19 | 2002-04-30 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
| AU9231998A (en) * | 1997-09-20 | 1999-04-12 | Osiris Therapeutics, Inc. | Antigen presenting mesenchymal stem cells |
| AT408615B (de) | 1998-09-15 | 2002-01-25 | Immuno Ag | Neue influenzavirus-impfstoffzusammensetzung |
| GB9923176D0 (en) | 1999-09-30 | 1999-12-01 | Smithkline Beecham Biolog | Novel composition |
| AU2002220265A1 (en) * | 2000-11-03 | 2002-05-15 | University Of Vermont And State Agricultural College | Compositions for inhibiting grb7 |
| JP2005531507A (ja) * | 2002-03-02 | 2005-10-20 | ザ ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | ストローマ細胞前駆体による抗癌物質の局所的な産生および／または送達方法 |
| CA2517396A1 (en) | 2003-02-28 | 2005-03-10 | Antigenics Inc. | Use of lectins to promote oligomerization of glycoproteins and antigenic molecules |
| AU2003903317A0 (en) | 2003-06-27 | 2003-07-10 | Proteome Systems Intellectual Property Pty Ltd | Method of isolating a protein |
| US20080095749A1 (en) * | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
| WO2005093044A1 (en) * | 2004-03-22 | 2005-10-06 | Osiris Therapeutics, Inc. | Mesenchymal stem cells and uses therefor |
| AR054822A1 (es) | 2005-07-07 | 2007-07-18 | Sanofi Pasteur | Emulsion inmuno adyuvante |
| KR101022401B1 (ko) * | 2005-09-29 | 2011-03-15 | 아주대학교산학협력단 | 자살유전자를 발현하는 중간엽 줄기세포를 포함하는 암치료용 조성물 |
| CN1887296B (zh) * | 2006-07-31 | 2011-05-25 | 南京大学生物制药工程研究中心 | 一种诱导抗肿瘤免疫的方法及其在制药中的应用 |
| US8685728B2 (en) * | 2008-01-31 | 2014-04-01 | Rutgers The State University Of New Jersey | Kit containing stem cells and cytokines for use in attenuating immune responses |
| US8771705B2 (en) | 2009-07-30 | 2014-07-08 | Healthbanks Biotech Co., Ltd. | Combination of protein vaccine and mesenchymal stem cells for treating cancer |
| KR20110038569A (ko) * | 2009-10-08 | 2011-04-14 | 주식회사 알앤엘바이오 | 인간 유래 성체 줄기세포를 함유하는 항암용 조성물 |
| JP2013510582A (ja) * | 2009-11-12 | 2013-03-28 | ザ テキサス エーアンドエム ユニバーシティー システム | 間葉幹細胞の球状集合体 |
| KR20120132183A (ko) * | 2011-05-27 | 2012-12-05 | 포항공과대학교 산학협력단 | 종양 조직에서 유래한 나노소포체 및 이를 이용한 암 백신 |
| DK2744892T3 (en) | 2011-09-23 | 2019-04-23 | Cell Ideas Pty Ltd | THERAPEUTICS USING FAT CELLS AND CELL SECRETIONS |
| US10357538B2 (en) * | 2012-12-24 | 2019-07-23 | Northern Sydney Local Health District | Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy |
-
2013
- 2013-12-24 US US14/655,088 patent/US10357538B2/en not_active Expired - Fee Related
- 2013-12-24 WO PCT/AU2013/001523 patent/WO2014100857A1/en not_active Ceased
- 2013-12-24 JP JP2015549902A patent/JP6286445B2/ja not_active Expired - Fee Related
- 2013-12-24 EP EP13867300.9A patent/EP2934578B1/en not_active Not-in-force
- 2013-12-24 AU AU2013370932A patent/AU2013370932B2/en not_active Ceased
- 2013-12-24 NZ NZ629700A patent/NZ629700A/en not_active IP Right Cessation
- 2013-12-24 EP EP18182531.6A patent/EP3446708A1/en not_active Withdrawn
- 2013-12-24 CA CA2934958A patent/CA2934958A1/en not_active Abandoned
-
2018
- 2018-02-02 JP JP2018017162A patent/JP2018111695A/ja active Pending
-
2019
- 2019-06-12 US US16/438,703 patent/US20190358291A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016505003A5 (enExample) | ||
| Darbre | Aluminium and the human breast | |
| Acunzo et al. | TCTP as therapeutic target in cancers | |
| Jeon et al. | Side-effect test of sorafenib using 3-D skin equivalent based on microfluidic skin-on-a-chip | |
| Ito et al. | Contrasting intra-and extracellular distribution of catalytic ferrous iron in ovalbumin-induced peritonitis | |
| Wang et al. | Toxic effects of environmental rare earth elements on delayed outward potassium channels and their mechanisms from a microscopic perspective | |
| Del Turco et al. | Cytocompatibility evaluation of glycol-chitosan coated boron nitride nanotubes in human endothelial cells | |
| Olsen et al. | Manipulation of cellular spheroid composition and the effects on vascular tissue fusion | |
| Herrera-Rincon et al. | Brief local application of progesterone via a wearable bioreactor induces long-term regenerative response in adult Xenopus hindlimb | |
| JP2017527260A5 (enExample) | ||
| Wu et al. | A selective reduction of osteosarcoma by mitochondrial apoptosis using hydroxyapatite nanoparticles | |
| Reding et al. | Manipulate intestinal organoids with niobium carbide nanosheets | |
| Roy et al. | Attenuation of cadmium-induced vascular toxicity by pro-angiogenic nanorods | |
| Chen et al. | Invisible bridges: unveiling the role and prospects of tunneling nanotubes in cancer therapy | |
| Chen et al. | Redox disruption using electroactive liposome coated gold nanoparticles for cancer therapy | |
| Nightingale et al. | The migrating gubernaculum grows like a “limb bud” | |
| Xie et al. | Mechanically stimulated osteocytes maintain tumor dormancy in bone metastasis of non-small cell lung cancer by releasing small extracellular vesicles | |
| Su et al. | Novel in situ biosynthesized fluorescent zinc nanoclusters for specific cellular bio-imaging | |
| Hussein et al. | Induction of caspase-dependent apoptosis in rat bone marrow mesenchymal stem cells due to Di-2-Ethylhexyl phthalate toxicity was found to arrest the cell cycle at the G1 stage | |
| Altundag et al. | The role of HSP90 in Quercetin-induced apoptosis in human papillary thyroid (B-CPAP) cancer cells | |
| Selc et al. | Surface coating determines the inflammatory potential of magnetite nanoparticles in murine renal podocytes and mesangial cells | |
| Bhardwaj et al. | Co-delivery of JQ1 and Gambogic acid through tumor-targeting PEGylated nanographene oxide with FSH beta peptide (33–53) identifies SNHG7-hsa-miR-324-3p-SMAD2 axis as a prognostic biomarker in ovarian cancer | |
| Sierant et al. | Identification and characterization of a novel nuclear structure containing members of the homologous recombination and DNA damage response pathways | |
| Fu et al. | Graphene oxide-supported berberine and aloe-emodin nanocomposites for dual-drug release and antimicrobial therapy | |
| RU2820551C1 (ru) | Средство, обладающее канцеропревентивным действием в отношении рака яичек и наследственного рака |